Evidence map›Paper›PMID 41047933›Full record

ReviewNeuropsychopharmacology reports2025

Organic Psychosis due to Lung Cancer Metastasis Accompanied by Severe Psychiatric Symptoms Treated With Blonanserin Transdermal Patch: A Case Report and Literature Review.

Junji Yamaguchi, Ryoichi Sadahiro, Saho Wada, Eri Nishikawa, Tatsuto Terada, Rika Nakahara, Hiromichi Matsuoka

Abstract readCase ReportsReview
In one paragraph

Review in Neuropsychopharmacology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junji YamaguchiNational Cancer Center Hospital, Tokyo, Japan.ORCID https://orcid.org/0009-0002-1356-7463
Ryoichi SadahiroNational Cancer Center Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2315-2771
Saho WadaNational Cancer Center Hospital, Tokyo, Japan.
Eri NishikawaNational Cancer Center Hospital, Tokyo, Japan.
Tatsuto TeradaNational Cancer Center Hospital, Tokyo, Japan.
Rika NakaharaNational Cancer Center Hospital, Tokyo, Japan.
Hiromichi MatsuokaNational Cancer Center Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7276-1971

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOrganic psychosis associated with brain metastasis from cancer occasionally presents with psychiatric symptoms such as delusions or violent behavior. In these cases, however, psychotropics may not be sufficiently effective, and their continuous use may also be difficult due to side effects. Besides, regular oral administration of psychotropics becomes more difficult when medication refusal develops. CASE PRESENTATION: A man in his 80s. At X-1 years, lung cancer was found to have metastasized to the right frontal lobe, with no apparent psychiatric symptoms. At X years, however, the patient was hospitalized because of consciousness disturbance, and new brain metastases in the right parietal and occipital lobes were detected. Irritability, violent behaviors, and delusions became dominant and required physical restraint. Refusal to take oral medications was also noted. Blonanserin transdermal patch (40 mg/day) was started along with an intravenous drip of haloperidol, and he became mentally calm, although psychiatric symptoms persisted with fluctuations. His mental status was finally stabilized with blonanserin transdermal patch (80 mg/day) with no side effects, leading to hospital discharge on Day 53 after admission.

conclusionsBlonanserin transdermal patch may be effective for organic psychosis associated with brain metastasis. Because it can be used in cases where oral medication is difficult and has relatively few side effects, such as hypotension and extrapyramidal symptoms, it may be a helpful option for oncologists and liaison psychiatrists.

Indexed as

Antipsychotic AgentsBrain NeoplasmsLung NeoplasmsPiperazinesPiperidinesPsychotic DisordersAged, 80 and overHumansMaleTransdermal PatchAntipsychotic AgentsblonanserinPiperazinesPiperidinesBlonanserin transdermal patchbrain metastasiscancerorganic psychosisrefusal of oral administration

Identifiers

PMID41047933
PMCPMC12498010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.